www.fdanews.com/articles/126257-celgene-deal-means-130-million-for-agios
Celgene Deal Means $130 Million for Agios
April 15, 2010
Agios Pharmaceuticals Inc. will receive a $130 million upfront payment, including an equity
investment, under an agreement with Celgene Corp., the two companies said Thursday.
boston
boston